Adjuvant Chemotherapy in Resected Lung Cancer: Two-Year Experience in a University Hospital

Nicole Bouchard; Francis Laberge; Bruno Raby; Sylvie Martin; Yves Lacasse

doi:10.1155/2008/462147

Canadian Respiratory Journal (Jan 2008)

Adjuvant Chemotherapy in Resected Lung Cancer: Two-Year Experience in a University Hospital

Nicole Bouchard,
Francis Laberge,
Bruno Raby,
Sylvie Martin,
Yves Lacasse

Affiliations

Nicole Bouchard: Clinique d’Oncologie Ambulatoire, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l’Université Laval, Quebec City, Quebec, Canada
Francis Laberge: Clinique d’Oncologie Ambulatoire, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l’Université Laval, Quebec City, Quebec, Canada
Bruno Raby: Clinique d’Oncologie Ambulatoire, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l’Université Laval, Quebec City, Quebec, Canada
Sylvie Martin: Clinique d’Oncologie Ambulatoire, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l’Université Laval, Quebec City, Quebec, Canada
Yves Lacasse: Clinique d’Oncologie Ambulatoire, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l’Université Laval, Quebec City, Quebec, Canada

DOI: https://doi.org/10.1155/2008/462147
Journal volume & issue: Vol. 15, no. 5
pp. 270 – 274

Abstract

Read online

BACKGROUND: Randomized trials have confirmed the benefits of adjuvant chemotherapy in improving survival in resected early-stage non-small-cell lung cancer (NSCLC). The extent to which these results have translated into clinical practice is unknown.

Published in Canadian Respiratory Journal

ISSN: 1198-2241 (Print); 1916-7245 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://onlinelibrary.wiley.com/journal/7503

About the journal